Door-to-GDMT time: The effect of de novo diagnosis of heart failure on guideline-directed medical therapy optimisation during the rapid-up titration programme and on prognosis

11 May 2026 (16:12 - 17:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Fanni Banfi-Bacsardi

Gottsegen National Cardiovascular Center, Budapest (Hungary)

6 More presentations in this session

Presentation thumbnail

Finerenone in everyday heart failure care

Doctor G. Mihelcic (London, GB)

Abstract Slides

Presentation thumbnail

Long-term maintenance of guideline-directed medical therapy and its prognostic impact in a community-based heart failure unit

Doctor M. Ferre-Vallverdu (Reus, ES)

Abstract Slides

Presentation thumbnail

Effect of colchicine after primary acute coronary syndrome in heart failure with preserved ejection fraction

Professor H. Hayrapetyan (Yerevan, AM)

Abstract Slides

Presentation thumbnail

Prognostic effect of rapid-up titration programme of guideline-directed medical therapy in heart failure: real-world experience from a multicentre observational study

Doctor Z. Forrai (Budapest, HU)

Abstract Slides

Presentation thumbnail

The applicability of vericiguat therapy in a real-world cohort of hospitalised patients with heart failure with reduced ejection fraction

Doctor Z. Forrai (Budapest, HU)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (6)

The Event

Event poster

Heart Failure 2026

11 May 2026 16:12 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources